Chengdu Easton Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 4.56% vs 14.14% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 10.00% vs 25.41% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "364.70",
          "val2": "348.80",
          "chgp": "4.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.50",
          "val2": "81.00",
          "chgp": "-8.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.50",
          "val2": "3.40",
          "chgp": "91.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "83.60",
          "val2": "76.00",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "204.30%",
          "val2": "171.90%",
          "chgp": "3.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.78% vs -4.41% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,336.30",
          "val2": "1,106.40",
          "chgp": "20.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "252.60",
          "val2": "228.50",
          "chgp": "10.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "3.70",
          "chgp": "5.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.90",
          "val2": "14.60",
          "chgp": "2.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "238.20",
          "val2": "226.60",
          "chgp": "5.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.80%",
          "val2": "139.00%",
          "chgp": "-1.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

364.70

348.80

4.56%

Operating Profit (PBDIT) excl Other Income

74.50

81.00

-8.02%

Interest

0.60

0.60

Exceptional Items

6.50

3.40

91.18%

Consolidate Net Profit

83.60

76.00

10.00%

Operating Profit Margin (Excl OI)

204.30%

171.90%

3.24%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 4.56% vs 14.14% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 10.00% vs 25.41% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,336.30

1,106.40

20.78%

Operating Profit (PBDIT) excl Other Income

252.60

228.50

10.55%

Interest

3.90

3.70

5.41%

Exceptional Items

14.90

14.60

2.05%

Consolidate Net Profit

238.20

226.60

5.12%

Operating Profit Margin (Excl OI)

125.80%

139.00%

-1.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 20.78% vs -4.41% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023

All Annual Results